Articles From: InnVest Real Estate Investment Trust Announces Rescheduling of Date of Third Quarter Earnings to Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy


2014/10/31
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0976383001&sourceType=1 http://media3.marketwire.com/logos/20140207-InnVEST.jpg TORONTO, ONTARIO --
Sign-up for InnVest Real Estate Investment Trust Announces Rescheduling of Date of Third Quarter Earnings investment picks
2014/12/8
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0983040001&sourceType=1 http://media3.marketwire.com/logos/20140207-InnVEST.jpg TORONTO, ONTARIO --
Sign-up for InnVest Real Estate Investment Trust Completes the Acquisition of the Hyatt Regency Vancouver investment picks
2014/11/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0977147001&sourceType=1 http://media3.marketwire.com/logos/20140207-InnVEST.jpg TORONTO, ONTARIO --
Sign-up for InnVest REIT Reports Third Quarter Results investment picks
GOLETA, Calif., Nov.
Sign-up for Inogen Announces Closing of Secondary Public Offering investment picks
GOLETA, Calif., Dec.
Sign-up for Inogen Announces Investor/Analyst Day and Webcast investment picks
GOLETA, Calif., Oct.
Sign-up for Inogen Announces Launch of Proposed Secondary Public Offering by Selling Stockholders investment picks
GOLETA, Calif., Oct.
Sign-up for Inogen Announces Preliminary Unaudited Third Quarter 2014 Revenue investment picks
GOLETA, Calif., Oct.
Sign-up for Inogen Announces Pricing of Secondary Public Offering investment picks
GOLETA, Calif., Dec.
Sign-up for Inogen Announces Reimbursement for the Inogen One G3 in Germany investment picks
GOLETA, Calif., Dec.
Sign-up for Inogen Discusses Oxygen Therapy Market and Future Growth Drivers at Investor/Analyst Day investment picks
GOLETA, Calif., Dec.
Sign-up for Inogen Expands Manufacturing Capacity to Accommodate Growth investment picks
- Q3 2014 Revenues Reflect 48.6% Year over Year Growth - GOLETA, Calif., Nov.
Sign-up for Inogen Releases Third Quarter 2014 Financial Results investment picks
GOLETA, Calif., Nov.
Sign-up for Inogen Selects JPMorgan Chase & Co. for Primary Banking Relationship investment picks
GOLETA, Calif., Oct.
Sign-up for Inogen to Announce Third Quarter 2014 Results on Tuesday, November 11, 2014 investment picks
GOLETA, Calif., Nov.
Sign-up for Inogen to Participate in Stifel 2014 Healthcare Conference investment picks
GOLETA, Calif., Dec.
Sign-up for Inogen to Participate in Upcoming Investor Conferences investment picks
2014/11/24
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1160987&ProfileId=051205&sourceType=1 BANNER ELK, NC --
Sign-up for INOL Announces Launch of Kumi Discovery Campaign investment picks
2014/11/4
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1156023&ProfileId=051205&sourceType=1 RALEIGH, NC --
Sign-up for INOL Announces New Product Line Under the Brand of Kumi investment picks
http://media.marketwire.com/attachments/201501/83212_masimo.jpg http://media.marketwire.com/attachments/201501/83213_inova.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1169174&ProfileId=051205&sourceType=1 FAIRFAX, VA and IRVINE, CA --
Sign-up for Inova Fair Oaks Hospital Casts Masimo Patient SafetyNet(TM) to Help Improve Patient Outcomes and Reduce Costs investment picks
2015/1/21
Inovalis Real Estate Investment Trust announces it has entered into an exclusivity agreement to purchase an office property in Germany with joint-venture partner Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES / TORONTO , Jan.
Sign-up for Inovalis Real Estate Investment Trust announces it has entered into an exclusivity agreement to purchase an office property in Germany with joint-venture partner investment picks
PLYMOUTH MEETING, Pa.
Sign-up for Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index investment picks
Dr. Yang led Janssen's prostate cancer and solid tumor therapeutic area in the U.S. PLYMOUTH MEETING, Pa.
Sign-up for Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology investment picks
Phase I Trial Reveals DNA Immunotherapy Results Were Similar To HIV-Infected Patients Whose Disease Did Not Progress PLYMOUTH MEETING, Pa.
Sign-up for Inovio Pharmaceuticals HIV Immunotherapy Shows Characteristics Considered Vital to Treating HIV investment picks
Active Immunotherapy Targets hTERT Gene Associated with 85% of Cancers Preclinical Studies Showed Tumor Shrinkage and Prevention of Tumor Recurrence PLYMOUTH MEETING, Pa.
Sign-up for Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers investment picks
Another Active Immunotherapy Product Added to Inovio's Growing Cancer R&D Pipeline PLYMOUTH MEETING, Pa.
Sign-up for Inovio Pharmaceuticals Melanoma DNA Immunotherapy Inhibits Tumor Growth and Increases Survival in Preclinical Study investment picks
PLYMOUTH MEETING, Pa.
Sign-up for Inovio Pharmaceuticals Reports 2014 Third Quarter Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: InnVest Real Estate Investment Trust Announces Rescheduling of Date of Third Quarter Earnings to Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent